中国医药科学Issue(24)：215-216,2.
顺铂联合放疗治疗中晚期食管癌预后分析
Analysis on prognosis of moderate and advanced esophageal carcinoma by cisplatin combined with radiotherapy
巴艳华1
作者信息
- 1. 郑州人民医院放疗科，河南郑州450003
- 折叠
摘要
Abstract
Objective To focus on and explore the clinical efficacy and safety of cisplatin combined with radiotherapy in the treatment of patients with moderate and advanced esophageal carcinoma. Methods The clinical data of 60 patients with moderate and advanced esophageal carcinoma who were treated in our hospital from January 1, 2010 to December 31, 2012 were studied and compared by using the retrospective analysis method. All patients were randomly divided into the two groups, 30 cases of the control group were given radiotherapy, while 30 cases of the observation group were treated with cisplatin based on the use of radiotherapy. Then the efficacy, patient's satisfaction rate and adverse reactions of patients in the two groups were analyzed and explored. Results The analysis of clinical data of 60 patients with moderate and advanced esophageal carcinoma treated in our hospital showed that the efficacy, patient's satisfaction rate and adverse reactions of patients in the observation group were significantly better than those in the control group(P<0.05). Conclusion Cisplatin combined with radiotherapy in the treatment of patients with moderate and advanced esophageal carcinoma has good clinical efficacy, good security, and has become the main treatment method for patients with moderate and advanced esophageal carcinoma now, has important value for the development of moderate and advanced esophageal carcinoma treatment in our country.关键词
顺铂/放疗/中晚期食管癌/预后分析Key words
Cisplatin/Radiotherapy/Moderate and advanced esophageal carcinoma/Prognosis analysis分类
医药卫生引用本文复制引用
巴艳华..顺铂联合放疗治疗中晚期食管癌预后分析[J].中国医药科学,2013,(24):215-216,2.
